智通财经APP获悉，三叶草生物-B(02197)涨超9%。截至发稿，涨9.33%，报2.93港元，成交额1.18亿港元。
高盛发研报称，三叶草生物完成配售1.28亿股，相当于公司经扩大后股本约9.91%，净筹约5亿元。该行上调公司今年及明年净利润预测各0.9%和0.6%，后年则下调0.7%，以反映净现金的变化。以经风险调整现金流折现率计，目标价由3.26港元上升至3.37港元，评级为“中性”。
港股异动 | 三叶草生物-B(02197)涨超9% 高盛上调公司目标价至3.37港元
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.